Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
galantamine (reminyl) (2009)
meloxicam (mobic) (2006)
sorafenib (nexavar) (2022)
globalagliatin (4 trials)
sy-005 (2 trials)
rifampin (1 trial)
sorafenib (nexavar) (1 trial)
sy-004 (1 trial)
sy-007 (1 trial)
sy-008 (2 trials)
sy-009 (2 trials)
maltodextrin (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Hyperglycemia (Phase 1)
Stroke (Phase 1)
Trials (15 total)
Trial APIs (9 total)